Epidemiology and health care burden of autoimmune liver diseases in Mexico
- PMID: 38379766
- PMCID: PMC10878547
- DOI: 10.1097/CLD.0000000000000089
Epidemiology and health care burden of autoimmune liver diseases in Mexico
Copyright © 2024 American Association for the Study of Liver Diseases.
Conflict of interest statement
Alan Bonder consults for Intercept. He received grants from Zydus Therapeutics, ChemomAb Ltd., Cymabay, Mirium Therapeutics, Intercept, Gilead, and CARA Therapeutics. The remaining authors have no conflicts to report.
Figures
References
-
- Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: Epidemiology of autoimmune liver diseases. Gut. 2021;70:1989–2003. - PubMed
-
- Consejo Nacional de Población (CONAPO), Dirección General de Estadística en Salud Pública (DGESP), Base de datos de las defunciones observadas en 2012, INEGI/SS» y «Proyecciones de la población de México, 2010-2030».
-
- Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis. J Clin Gastroenterol. 2012;46:155–61. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
